| European Case Law Identifier: | ECLI:EP:BA:2012:T041511.20120112 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 12 January 2012 | ||||||||
| Case number: | T 0415/11 | ||||||||
| Application number: | 00992589.2 | ||||||||
| IPC class: | A61K 39/385 A61K 39/095 A61K 47/22 A61K 47/26 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Compositions and methods for stabilizing biological molecules upon lyophilization | ||||||||
| Applicant name: | Novartis Vaccines and Diagnostics, Inc. | ||||||||
| Opponent name: | GlaxoSmithKline Biologicals s.a. | ||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Main request and auxiliary requests 1 to 8 - inventive step (no) | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t110415eu1.html
Date retrieved: 17 May 2021